open access

Vol 50, No 3 (2012)
Original paper
Submitted: 2012-10-08
Accepted: 2012-10-08
Published online: 2012-10-08
Get Citation

Total antioxidant status (TAS) in childhood cancer survivors

Maryna Krawczuk-Rybak, Anna Panasiuk, Małgorzata Czygier, Katarzyna Muszynska-Roslan, Jolanta Wysocka, Maciej Szmitkowski
DOI: 10.5603/FHC.2012.0065
·
Folia Histochem Cytobiol 2012;50(3):468-472.

open access

Vol 50, No 3 (2012)
ORIGINAL PAPERS
Submitted: 2012-10-08
Accepted: 2012-10-08
Published online: 2012-10-08

Abstract

Total antioxidant status (TAS), and the influence of treatment and correlation between TAS and parameters
involved in metabolic syndrome (MS) in pediatric cancer survivors were evaluated. One hundred children
and adolescents were studied. Twenty-five survivors received radiotherapy, 12 were obese or overweight.
Additionally, we analyzed TAS in eight children with acute lymphoblastic leukemia (ALL) at diagnosis and
during treatment after remission induction. The control group consisted of 22 healthy children. Serum concentrations
of TAS, glucose, cholesterol, HDL-cholesterol, triglycerides, fibrinogen and insulin were measured. In
cancer survivors, independently of diagnosis and kind of treatment (radiotherapy anthracyclines administration),
the mean serum TAS did not differ significantly from the control group. No correlations were observed
with age at the time of diagnosis or interval after the end of treatment. TAS values did not correlate with traits of
the metabolic syndrome. In a group of eight patients with ALL at diagnosis and after induction of remission,
TAS values were lower than in the control and cancer survivor groups. Antioxidant status was not found to be
deteriorated in children after anticancer treatment, irrespective of diagnosis or kind of treatment, which might
indicate sufficient antioxidant prevention. However, the possibility of the development of MS and cardiovascular
disease in adulthood indicates the need for future studies.

Abstract

Total antioxidant status (TAS), and the influence of treatment and correlation between TAS and parameters
involved in metabolic syndrome (MS) in pediatric cancer survivors were evaluated. One hundred children
and adolescents were studied. Twenty-five survivors received radiotherapy, 12 were obese or overweight.
Additionally, we analyzed TAS in eight children with acute lymphoblastic leukemia (ALL) at diagnosis and
during treatment after remission induction. The control group consisted of 22 healthy children. Serum concentrations
of TAS, glucose, cholesterol, HDL-cholesterol, triglycerides, fibrinogen and insulin were measured. In
cancer survivors, independently of diagnosis and kind of treatment (radiotherapy anthracyclines administration),
the mean serum TAS did not differ significantly from the control group. No correlations were observed
with age at the time of diagnosis or interval after the end of treatment. TAS values did not correlate with traits of
the metabolic syndrome. In a group of eight patients with ALL at diagnosis and after induction of remission,
TAS values were lower than in the control and cancer survivor groups. Antioxidant status was not found to be
deteriorated in children after anticancer treatment, irrespective of diagnosis or kind of treatment, which might
indicate sufficient antioxidant prevention. However, the possibility of the development of MS and cardiovascular
disease in adulthood indicates the need for future studies.
Get Citation
About this article
Title

Total antioxidant status (TAS) in childhood cancer survivors

Journal

Folia Histochemica et Cytobiologica

Issue

Vol 50, No 3 (2012)

Article type

Original paper

Pages

468-472

Published online

2012-10-08

DOI

10.5603/FHC.2012.0065

Bibliographic record

Folia Histochem Cytobiol 2012;50(3):468-472.

Authors

Maryna Krawczuk-Rybak
Anna Panasiuk
Małgorzata Czygier
Katarzyna Muszynska-Roslan
Jolanta Wysocka
Maciej Szmitkowski

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl